-
One more program to confuse us when needing a prescription, although I’m sure there is money to be saved here, but shoot I like the $4.00 or $10.00 generic prescriptions offered by others, no enrollment and no questions asked, simple. For the monthly fee, you might need to be a patient with some...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-06-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, Other Items of Interest, drugs, healthcare, health insurance, Prescriptions, Medicare Part D, Aetna, Pharmacy, Costco
-
I will once more mention a potential change of paradigms here with educating the public. Each patient who took the drug is unique. Do we have any information on other drugs they were taking at the same time? Groups will continue to advise against the use until the full facts are known...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, healthcare, Pharma, PHR, FDA, Marketing, paradigms, personal heatlh records
-
Even folks with money and in high positions have problems getting access to cancer drugs, as you can read below, and this was not an issue of not being able to afford the medication. When you read items as such, it makes you stop and think how precious life and healthcare really is. BD ...
-
New program to educate pharmacists on pharmacogenomics. The efforts are going forward to help the pharmacists also explain to the patients how it works and what the information has to offer. The new group of graduates will be the first group of pharmacists to be information equipped. ...
-
Investors and analysts using The Healthcare Exchange will be able to ask questions of physicians, such as their opinions about a new treatment or device. Sermo has been a community website restricted to physicians to compare and collaborate within their peers and now with the new service investors...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-23-2008
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, drugs, healthcare, Investors, Physicians, Prescriptions, clinical trials, Sermo, Bloomberg, MCconnect, opinions
-
I wonder if all the name brand companies will one day have nothing but generics? (grin). There’s always this interesting topic too, biosimilars. “Because biosimilars aren't exact duplicates of the original drugs, they don't violate the original drug's patent , enabling legal distribution...
-
Whistle blowers today seem to be playing a role in the move towards transparency in more ways than one, not to mention the bounty that could be there if a case goes to court and wrongdoing is found to be the case. BD A New Jersey arbitrator ruled that a former Amgen sales rep can proceed with a...
-
Whistle blower case where Pharma Sales representative created an investigation and settlement. Whistle blowers can and do receive portions of settlements, and in this case there was $46 million. The uses marketed by Cephalon were not approved by the FDA. Doctors can prescribe...
-
The drug evaluation department has the largest increase, and oncologists were difficult to find as most make more money on the outside. I wonder if they can find enough for the drug side of the business, as it is changing every day with new applications and with more information to review, it's...
-
Interesting article with some good background information about drugs that are close to or are related to the "street drugs" as we know them. There are definitely a number of researchers who want to delve into this further, but with bad raps and being illegal in their "street drug"...
-
I spent a little time looking around today and there are many "red stars" on this page, which indicate a safety alert from the FDA. Safety alerts come in all shapes and sizes and a red start does not mean to stop taking medications by any means, just an awareness to help both the clinicians...
-
Interesting correlation on how the move business and Pharma share similar business plans when it comes to producing a blockbuster drug. R and D, yup, got high costs with both, unpredictable, yup, nobody knows until the release, budgets and flops, well it could be a toss up over which industry can...
-
Roche has been all over the news this week and one more claim to fame to their technology was the ability to catch an athlete cheating. Athletes still keep trying but hopefully efforts like this will keep the competition honest and fair, nobody wants a cheater to win. BD Ricardo Ricco...
-
Intellectual Property on the auction block, patents with FDA approval. This is the first time I have noticed technology with health care just up on the open auction block, especially as it relates to cancer research. With the acquisition, it must not fit into the same business model...
-
When you stop and think about it, this makes sense to be the “informed patient”. The less time a physician has to take and explain things to you, that you have already read about on the Internet, the more constructive time you will have . This really goes for any meeting done today, but...